Biomarkers May Aid in Early Diagnosis of Alzheimer’s
New research suggests that biomarkers in the blood may help diagnose Alzheimer's disease before it progresses, potentially opening the door to better treatments.
While there are currently no treatments that can halt or delay the onset of the disease, the hope is that being able to diagnose Alzheimer's earlier could provide clues about what medication might prevent it from getting worse, the study authors said.
"Most of the research to this point has been done on those who already have Alzheimer's disease," said study author Sid O'Bryant, director of research for the F. Marie Hall Institute for Rural and Community Health at Texas Tech University Health Sciences Center. "We need to be able to identify those at greatest risk."
- $6.4B Henry Ford, Beaumont Merger Failed on Cultural Hurdles
- Fortunately, Angelina Jolie Isn't On Medicare
- House Lawmakers Grill CMS Over Health Exchange Navigators
- Don't Let Nurses Sink Your Bottom Line
- How Chargemaster Data May Affect Hospital Revenue
- Hospital Pricing Transparency a Marketing Game Changer
- Uncompensated Care Faces a Double Hit in Some States
- Hospitals Profit On Bloodstream Infections
- Primary Care Docs Average More Hospital Revenue Than Specialists
- ED Physicians Key to Half of Hospital Admissions